← Back to Clinical Trials
Recruiting NCT07558876

NCT07558876 Task-Oriented Upper Limb Training With Focal Vibration in Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07558876
Status Recruiting
Phase
Sponsor Jisu Kim
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 38 participants
Start Date 2026-04-27
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
ask-oriented upper limb training combined with focal vibrationActive Comparator: Task-Oriented Upper Limb Training Alone

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 38 participants in total. It began in 2026-04-27 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effects of task-oriented upper limb training combined with focal vibration on hand function, proprioception, and muscle tone in patients with stroke. Participants will be randomly assigned to either an experimental group receiving task-oriented training with concurrent focal vibration or a control group receiving task-oriented training alone. The intervention will be conducted over 6 weeks. Outcome measures will be assessed before and after the intervention.

Eligibility Criteria

Inclusion Criteria: * Individuals diagnosed with stroke at least 3 months prior * Individuals with sufficient cognitive function (Mini-Mental State Examination \[MMSE\] score ≥ 24) * Individuals able to maintain a seated position independently and perform upper limb functional tasks (Trunk Control Test \[TCT\] ≥ 50) * Individuals with muscle tone of the affected upper limb of Modified Ashworth Scale (MAS) Grade ≤ 2 * Individuals with Fugl-Meyer Assessment-Upper Extremity (FMA-UE) scores between 20 and 50 * Individuals able to grasp and move objects with the affected upper limb and with muscle strength of Manual Muscle Test (MMT) Grade ≥ 3 * Individuals with impaired proprioception in the affected hand (defined as a score \< 2 on the wrist or thumb position item of the FMA-UE) Exclusion Criteria: * Individuals within 3 months after stroke onset * Individuals with fractures, severe soft tissue injuries, or contraindications to focal vibration * Individuals with severe sensory hypersensitivity or complex regional pain syndrome (CRPS) * Individuals who received treatments affecting upper limb function within the past 3 months (e.g., botulinum toxin injection, surgery, nerve block)

Contact & Investigator

Central Contact

Jisu Kim, PT

✉ ksuu6639@naver.com

📞 +82-10-8362-6639

Frequently Asked Questions

Who can join the NCT07558876 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07558876 currently recruiting?

Yes, NCT07558876 is actively recruiting participants. Contact the research team at ksuu6639@naver.com for enrollment information.

Where is the NCT07558876 trial being conducted?

This trial is being conducted at Seoul, South Korea, Seoul, South Korea.

Who is sponsoring the NCT07558876 clinical trial?

NCT07558876 is sponsored by Jisu Kim. The trial plans to enroll 38 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology